Published in J Cardiovasc Magn Reson on November 24, 2009
Feature tracking measurement of dyssynchrony from cardiovascular magnetic resonance cine acquisitions: comparison with echocardiographic speckle tracking. J Cardiovasc Magn Reson (2013) 1.00
Validation and Development of a New Automatic Algorithm for Time-Resolved Segmentation of the Left Ventricle in Magnetic Resonance Imaging. Biomed Res Int (2015) 0.85
Nonechocardiographic imaging in evaluation for cardiac resynchronization therapy. Circ Cardiovasc Imaging (2011) 0.82
Cardiac resynchronization therapy guided by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 0.79
Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy. Heart Fail Rev (2011) 0.78
Details of left ventricular radial wall motion supporting the ventricular theory of the third heart sound obtained by cardiac MR. Br J Radiol (2014) 0.77
Review of Journal of Cardiovascular Magnetic Resonance 2009. J Cardiovasc Magn Reson (2010) 0.75
Review of journal of cardiovascular magnetic resonance 2010. J Cardiovasc Magn Reson (2011) 0.75
The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med (2005) 20.72
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med (2004) 18.38
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol (2000) 16.47
Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation (2008) 7.11
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol (2006) 5.58
Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol (2004) 3.87
Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med (2007) 3.61
Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. J Am Coll Cardiol (2003) 2.78
Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol (2008) 2.75
Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc Imaging (2008) 2.64
Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol (2004) 2.63
High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart (2003) 2.25
A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. J Am Coll Cardiol (2008) 1.81
Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol (2006) 1.70
Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy. J Am Coll Cardiol (2006) 1.68
Prevalence of echocardiographically detected ventricular asynchrony in patients with left ventricular systolic dysfunction. J Am Soc Echocardiogr (2005) 1.59
Three-dimensional mapping of optimal left ventricular pacing site for cardiac resynchronization. Circulation (2007) 1.56
Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. J Am Coll Cardiol (2007) 1.30
Electrical and mechanical components of dyssynchrony in heart failure patients with normal QRS duration and left bundle-branch block: impact of left and biventricular pacing. Circulation (2004) 1.24
An epidemic of dyssynchrony: but what does it mean? J Am Coll Cardiol (2008) 1.24
Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. J Am Coll Cardiol (2008) 0.98
Regional left ventricle mechanical asynchrony in patients with heart disease and normal QRS duration: implication for biventricular pacing therapy. Pacing Clin Electrophysiol (2003) 0.91
Assessment of longitudinal and radial ventricular dyssynchrony in ischemic and nonischemic chronic systolic heart failure: a two-dimensional echocardiographic speckle-tracking strain study. J Am Soc Echocardiogr (2007) 0.90
Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex. J Am Coll Cardiol (2007) 0.86
Prevalence of mechanical dyssynchrony in heart failure patients with different QRS durations. Pacing Clin Electrophysiol (2007) 0.86
Assessment of cardiac asynchrony by radionuclide phase analysis: correlation with ventricular function in patients with narrow or prolonged QRS interval. Eur J Heart Fail (2007) 0.85
Frequency of inter- and intraventricular dyssynchrony in patients with heart failure according to QRS width. Europace (2007) 0.85
QRS duration alone misses cardiac dyssynchrony in a substantial proportion of patients with chronic heart failure. J Am Soc Echocardiogr (2006) 0.84
Relation of left ventricular systolic dyssynchrony in patients with heart failure to left ventricular ejection fraction and to QRS duration. Am J Cardiol (2008) 0.83
Vasorelaxation by red blood cells and impairment in diabetes: reduced nitric oxide and oxygen delivery by glycated hemoglobin. Circ Res (2004) 3.99
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation (2003) 3.89
Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation (2008) 2.75
The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol (2009) 2.61
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol (2005) 2.28
Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation (2010) 2.25
Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol (2002) 2.14
Metabolic mechanisms in heart failure. Circulation (2007) 2.06
The limit of plausibility for predictors of response: application to biventricular pacing. JACC Cardiovasc Imaging (2012) 1.67
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. Eur Heart J (2007) 1.65
Prognostic role of CMR in patients presenting with ventricular arrhythmias. JACC Cardiovasc Imaging (2013) 1.62
Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study. Eur J Heart Fail (2011) 1.61
Cardiac resynchronisation therapy in patients with heart failure and a normal QRS duration: the RESPOND study. Heart (2011) 1.56
Short-term hemodynamic effects of cardiac resynchronization therapy in patients with heart failure, a narrow QRS duration, and no dyssynchrony. Circulation (2009) 1.51
Fluoroscopic left ventricular lead position and the long-term clinical outcome of cardiac resynchronization therapy. Pacing Clin Electrophysiol (2011) 1.44
Acute heart failure: focusing on acute cardiogenic pulmonary oedema. Clin Med (2010) 1.39
Haemodynamics of cardiac arrest and resuscitation. Curr Opin Crit Care (2006) 1.34
Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs. Heart (2007) 1.30
Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. J Am Coll Cardiol (2007) 1.30
Electrical and mechanical components of dyssynchrony in heart failure patients with normal QRS duration and left bundle-branch block: impact of left and biventricular pacing. Circulation (2004) 1.24
Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nat Clin Pract Cardiovasc Med (2008) 1.13
Inhibition of cortisol production with metyrapone prevents mental stress-induced endothelial dysfunction and baroreflex impairment. J Am Coll Cardiol (2005) 1.13
Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2011) 1.11
Rapid nongenomic aldosterone effects in the human forearm? Hypertension (2004) 1.11
Complete atrioventricular block DOES reduce mortality in patients with atrial fibrillation treated with cardiac resynchronization therapy. Eur J Heart Fail (2013) 1.10
Cardiac resynchronization via the femoral vein: a novel method in cases with contraindications to the pectoral approach. Europace (2006) 1.10
Left ventricular non-compaction: clinical features and cardiovascular magnetic resonance imaging. BMC Cardiovasc Disord (2009) 1.07
Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace (2007) 1.07
Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon. Europace (2013) 1.06
Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. J Am Coll Cardiol (2012) 1.03
What is treatment success in cardiac resynchronization therapy? Europace (2009) 1.02
Detection of human red blood cell-bound nitric oxide. J Biol Chem (2005) 1.01
Myocardial infarction does not preclude electrical and hemodynamic benefits of cardiac resynchronization therapy in dyssynchronous canine hearts. Circ Arrhythm Electrophysiol (2010) 1.01
Left ventricular reverse remodelling, long-term clinical outcome, and mode of death after cardiac resynchronization therapy. Eur J Heart Fail (2010) 0.99
When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio) in optimization of cardiac resynchronization therapy, and how to measure and maximize it. Heart Fail Rev (2011) 0.99
Risk factors for outbreaks of multidrug-resistant Klebsiella pneumoniae in critical burn patients. J Burn Care Res (2012) 0.99
Mitral annular plane systolic excursion on exercise: a simple diagnostic tool for heart failure with preserved ejection fraction. Eur J Heart Fail (2011) 0.98
Metyrapone improves endothelial dysfunction in patients with treated depression. J Am Coll Cardiol (2006) 0.97
Letter by Taylor et al regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study". Circ Cardiovasc Imaging (2013) 0.95
The role of vascular myoglobin in nitrite-mediated blood vessel relaxation. Cardiovasc Res (2010) 0.95
Perhexiline. Cardiovasc Drug Rev (2007) 0.95
Arterial distensibility: acute changes following dynamic exercise in normal subjects. Am J Physiol Heart Circ Physiol (2002) 0.94
Right ventricular function in left ventricular disease: pathophysiology and implications. Heart Lung Circ (2013) 0.92
High-intensity exercise attenuates postprandial lipaemia and markers of oxidative stress. Clin Sci (Lond) (2012) 0.92
The frequency of vascular complications associated with the use of vascular closure devices varies by indication for cardiac catheterization. Clin Res Cardiol (2011) 0.92
Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure. Arterioscler Thromb Vasc Biol (2004) 0.91
NO metabolite flux across the human coronary circulation. Cardiovasc Res (2007) 0.91
Conjugated linoleic acid impairs endothelial function. Arterioscler Thromb Vasc Biol (2005) 0.91
Baroreflex sensitivity is reduced in depression. Psychosom Med (2005) 0.90
New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Europace (2013) 0.88
Can we make sense of takotsubo cardiomyopathy? An update on pathogenesis, diagnosis and natural history. Expert Rev Cardiovasc Ther (2012) 0.88
Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure. Europace (2009) 0.87
Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacity. Am Heart J (2010) 0.87
Integration of the metabolic and cardiovascular effects of exercise. Essays Biochem (2006) 0.87
Comparison of left ventricular-biventricular pacing on ventricular synchrony, mitral regurgitation, and global left ventricular function in patients with severe chronic heart failure. Am J Cardiol (2004) 0.87
Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population. Europace (2008) 0.86
Mechanisms of reduction of mitral regurgitation by cardiac resynchronization therapy. J Am Soc Echocardiogr (2007) 0.86
Wave intensity analysis from the common carotid artery: a new noninvasive index of cerebral vasomotor tone. Heart Vessels (2003) 0.86
Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure). J Am Coll Cardiol (2013) 0.85
Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite. Br J Pharmacol (2013) 0.84
Role of nitric oxide and oxidative stress in baroreceptor dysfunction in patients with chronic heart failure. Clin Sci (Lond) (2003) 0.84
Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario. Europace (2011) 0.84
Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study. Int J Cardiol (2004) 0.84
Pacing-induced increase in QT dispersion predicts sudden cardiac death following cardiac resynchronization therapy. J Am Coll Cardiol (2006) 0.84
Metabolic modulation in heart failure: the coming of age. Cardiovasc Drugs Ther (2007) 0.84
Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association. Eur Heart J (2013) 0.83
Increased atrial contribution to left ventricular filling compensates for impaired early filling during exercise in heart failure with preserved ejection fraction. J Card Fail (2009) 0.83
Assessment of venous capacitance. Radionuclide plethysmography: methodology and research applications. Br J Clin Pharmacol (2002) 0.82
Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis. PLoS One (2011) 0.82
Reversal of inappropriate peripheral vascular responses in hypertrophic cardiomyopathy. J Am Coll Cardiol (2005) 0.82
Atrial fibrillation burden during the post-implant period after crt using device-based diagnostics. J Cardiovasc Electrophysiol (2006) 0.82
Pacing in congestive heart failure. Curr Control Trials Cardiovasc Med (2000) 0.81
Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines. Pacing Clin Electrophysiol (2009) 0.81
Validation of Seattle Heart Failure Model for mortality risk prediction in patients treated with cardiac resynchronization therapy. Eur J Heart Fail (2012) 0.81
Reduced in vivo skeletal muscle oxygen consumption in patients with chronic heart failure--a study using Near Infrared Spectrophotometry (NIRS). Eur J Heart Fail (2008) 0.81
Outcomes with respect to disabilities of the upper limb after hand allograft transplantation: a systematic review. Transpl Int (2012) 0.81
Pediatric hand trauma. Clin Orthop Relat Res (2005) 0.81
Incidental cardiac findings on computed tomography imaging of the thorax. BMC Res Notes (2010) 0.80